
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Grace Guzman, Megan R. Reed, Kevin Bielamowicz, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 5, pp. 479-489
Open Access | Times Cited: 77
Grace Guzman, Megan R. Reed, Kevin Bielamowicz, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 5, pp. 479-489
Open Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
A Comprehensive Review of Various Therapeutic Strategies for the Management of Skin Cancer
Sudharshan Reddy Dachani, Mohammed Kaleem, Md Ali Mujtaba, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10030-10048
Open Access | Times Cited: 14
Sudharshan Reddy Dachani, Mohammed Kaleem, Md Ali Mujtaba, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10030-10048
Open Access | Times Cited: 14
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Yannick Bulliard, Börje S. Andersson, Mehmet A. Baysal, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24
Yannick Bulliard, Börje S. Andersson, Mehmet A. Baysal, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24
In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials
Shihong Nie, Yuyang Qin, Liyuan Ou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 9
Shihong Nie, Yuyang Qin, Liyuan Ou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 9
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches
Natalie Fuchs, Longfei Zhang, Laura Calvo‐Barreiro, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access | Times Cited: 8
Natalie Fuchs, Longfei Zhang, Laura Calvo‐Barreiro, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access | Times Cited: 8
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Vahid Moradi, Elnaz Khodabandehloo, Mehdi Alidadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 6
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 6
Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy
Anna Barata, Tejaswini Dhawale, Richard Newcomb, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 452.e1-452.e11
Closed Access | Times Cited: 5
Anna Barata, Tejaswini Dhawale, Richard Newcomb, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 452.e1-452.e11
Closed Access | Times Cited: 5
HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice
Jianting Long, Xihe Chen, Mian He, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Jianting Long, Xihe Chen, Mian He, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapy
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 5
Valentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1124-1134
Closed Access | Times Cited: 5
Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy
Maryam Sahlolbei, Amirhossein Ahmadieh-Yazdi, Mohadeseh Rostamipoor, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 5
Maryam Sahlolbei, Amirhossein Ahmadieh-Yazdi, Mohadeseh Rostamipoor, et al.
IntechOpen eBooks (2024)
Open Access | Times Cited: 5
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
Danqing Zhu, Wonjoon Kim, Hyunjin Lee, et al.
Advanced Materials (2025)
Closed Access
Danqing Zhu, Wonjoon Kim, Hyunjin Lee, et al.
Advanced Materials (2025)
Closed Access
CAR-T Cell Therapy for Solid Tumors
Liz T. Tony, Andrea Stabile, Marc Philipp Schauer, et al.
Transfusion Medicine and Hemotherapy (2025), pp. 1-13
Open Access
Liz T. Tony, Andrea Stabile, Marc Philipp Schauer, et al.
Transfusion Medicine and Hemotherapy (2025), pp. 1-13
Open Access
Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
Pui Yeng Lam, Natacha Omer, J. Wong, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Pui Yeng Lam, Natacha Omer, J. Wong, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access
Engineered extracellular vesicles with DR5 agonistic scFvs simultaneously target tumor and immunosuppressive stromal cells
Yeye Guo, Huaishan Wang, Shujing Liu, et al.
Science Advances (2025) Vol. 11, Iss. 3
Closed Access
Yeye Guo, Huaishan Wang, Shujing Liu, et al.
Science Advances (2025) Vol. 11, Iss. 3
Closed Access
Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy
Riccardo Caraffi, Giulia Rovesti, Arianna Rinaldi, et al.
Elsevier eBooks (2025), pp. 315-358
Closed Access
Riccardo Caraffi, Giulia Rovesti, Arianna Rinaldi, et al.
Elsevier eBooks (2025), pp. 315-358
Closed Access
From antibodies to nanobodies: The next frontier in cancer theranostics for solid tumors
Sanjana Mehrotra, Navdeep Kaur, Sukhpreet Kaur, et al.
Advances in protein chemistry and structural biology (2025)
Closed Access
Sanjana Mehrotra, Navdeep Kaur, Sukhpreet Kaur, et al.
Advances in protein chemistry and structural biology (2025)
Closed Access
Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond
Zishan Yang, Boram Ha, Qinhan Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zishan Yang, Boram Ha, Qinhan Wu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
RESET: A reversible TCR-coupled antigen receptor with superior targeting sensitivity and pharmacologically controlled anti-tumor activity
Jardin Leleux, Jillian Rosenberg, Olmo Sonzogni, et al.
Molecular Therapy (2025)
Open Access
Jardin Leleux, Jillian Rosenberg, Olmo Sonzogni, et al.
Molecular Therapy (2025)
Open Access
Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy
Viswatej Avutu, Jumanah N Algazaq, Kenneth Seier, et al.
Transplantation and Cellular Therapy (2025)
Closed Access
Viswatej Avutu, Jumanah N Algazaq, Kenneth Seier, et al.
Transplantation and Cellular Therapy (2025)
Closed Access
CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View
Sara Capolla, Maria Rasool, Giuseppe Toffoli, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Sara Capolla, Maria Rasool, Giuseppe Toffoli, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Novel Therapeutic Options for Small Cell Lung Cancer
Stefania Canova, Benedetta Trevisan, Maria Ida Abbate, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 11, pp. 1277-1294
Open Access | Times Cited: 12
Stefania Canova, Benedetta Trevisan, Maria Ida Abbate, et al.
Current Oncology Reports (2023) Vol. 25, Iss. 11, pp. 1277-1294
Open Access | Times Cited: 12
Label free metabolic imaging to enhance the efficacy of Chimeric Antigen Receptor T cell therapy
Dan L. Pham, Daniel Cappabianca, Matthew H. Forsberg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Dan L. Pham, Daniel Cappabianca, Matthew H. Forsberg, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Deciphering the importance of culture pH on CD22 CAR T-cells characteristics
Michaela Procházková, Alexandra Dreyzin, Lipei Shao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Michaela Procházková, Alexandra Dreyzin, Lipei Shao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Insights into Personalized Care Strategies for Wilms Tumor: A Narrative Literature Review
Salma Karam, Ahmad Gebreil, Ahmed Alksas, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1455-1455
Open Access | Times Cited: 3
Salma Karam, Ahmad Gebreil, Ahmed Alksas, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1455-1455
Open Access | Times Cited: 3